Yeon-sil Kim

St. Vincent's Hospital
Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Reproducibility and Potential Prognostic Value of Spatial Metabolic PET Metrics in Oral Tongue Squamous Cell Carcinoma.

Reproducibility and Potential Prognostic Value of Spatial Metabolic PET Metrics in Oral Tongue Squamous Cell Carcinoma.

Journal: Cancers

Published: July 09, 2026

FDG PET/CT for Postoperative Surveillance in Malignant Pleural Mesothelioma: Temporal Evolution of Postsurgical Metabolic Activity and Diagnostic Performance for Recurrence Detection.

FDG PET/CT for Postoperative Surveillance in Malignant Pleural Mesothelioma: Temporal Evolution of Postsurgical Metabolic Activity and Diagnostic Performance for Recurrence Detection.

Journal: Cancers

Published: May 26, 2026

Dosimetric comparison of TomoTherapy and non-coplanar VMAT for hippocampal-avoidance prophylactic cranial irradiation.

Dosimetric comparison of TomoTherapy and non-coplanar VMAT for hippocampal-avoidance prophylactic cranial irradiation.

Journal: Frontiers in oncology

Published: January 19, 2026

Non-Response to Durvalumab and Supraclavicular Nodal Involvement Predict Early Brain Metastasis After CCRT Followed by Durvalumab Consolidation in Stage III NSCLC.

Non-Response to Durvalumab and Supraclavicular Nodal Involvement Predict Early Brain Metastasis After CCRT Followed by Durvalumab Consolidation in Stage III NSCLC.

Journal: Cancer research and treatment

Published: November 11, 2025

Head and neck squamous cell carcinoma following allogeneic bone marrow transplantation: Clinical features, genomic Alterations, and limited efficacy of palliative chemotherapy.

Head and neck squamous cell carcinoma following allogeneic bone marrow transplantation: Clinical features, genomic Alterations, and limited efficacy of palliative chemotherapy.

Journal: Oral oncology

Published: October 01, 2025

Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.

Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.

Journal: Histopathology

Published: August 20, 2025

High-Risk Early-Stage Endometrial Cancer: Role of Adjuvant Therapy and Prognostic Factors Affecting Survival.

High-Risk Early-Stage Endometrial Cancer: Role of Adjuvant Therapy and Prognostic Factors Affecting Survival.

Journal: Cancers

Published: April 28, 2025

Can lymphocytic toxicity be induced by radiation dose to the bowel bag in whole pelvic radiotherapy?

Can lymphocytic toxicity be induced by radiation dose to the bowel bag in whole pelvic radiotherapy?

Journal: Radiation oncology journal

Published: April 08, 2025

Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial).

Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial).

Journal: Journal of gynecologic oncology

Published: February 25, 2025

Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer.

Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer.

Journal: Radiation oncology journal

Published: February 08, 2024

Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 3. Genitourinary and gynecological cancers.

Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 3. Genitourinary and gynecological cancers.

Journal: Radiation oncology journal

Published: December 25, 2023

Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer).

Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer).

Journal: Radiation oncology journal

Published: November 10, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026